Cargando…
Risk of colitis in immune checkpoint inhibitors and in chemotherapy/placebo for solid tumors: a systematic review and meta-analysis
BACKGROUND: We conducted a systematic review and meta-analysis in an attempt to evaluate the risk of colitis in immune checkpoint inhibitors (ICIs) and in chemotherapy/placebo for solid tumors. METHODS: Embase and PubMed were searched with specific keywords of our concern. Collected data were proces...
Autores principales: | Wei, Wei, Ding, Yun, He, Jiajia, Wu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798055/ https://www.ncbi.nlm.nih.gov/pubmed/35117786 http://dx.doi.org/10.21037/tcr-19-2872 |
Ejemplares similares
-
Risk of Immune-Related Pancreatitis in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors: Systematic Assessment with Meta-Analysis
por: Su, Qiang, et al.
Publicado: (2018) -
The safety of combining immune checkpoint inhibitors and platinum-based chemotherapy for the treatment of solid tumors: A systematic review and network meta-analysis
por: Mei, Ting, et al.
Publicado: (2023) -
Retreatment with immune checkpoint inhibitors in solid tumors: a systematic review
por: Yang, Kaili, et al.
Publicado: (2020) -
Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
por: Liu, Xiangxing, et al.
Publicado: (2022) -
Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis
por: Abu-Sbeih, Hamzah, et al.
Publicado: (2019)